Status: Recruiting
Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers
This study aims to compare two treatment approaches for diabetic foot ulcers (DFUs): the standard of care (SOC) alone versus SOC combined with OCM. Researchers will evaluate whether adding OCM increases the likelihood of ulcers healing completely by the end of the trial period.
Participants needed: 130
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Omeza, LLCUpdated: Jun 15, 2026Locations: 10
Eligibility criteria
Male or Female, 18 years of age or older [+14]
Subject has a known life expectance of <1 year [+14]